In this MasterClass, Dr. Devries discusses environmental conditions that can cause dry eye flares. By the end of this class, you will learn what causes a dry eye flare, how often dry eye flares occur, and how to diagnose and manage these flares.
This activity is supported by an unrestricted educational grant from Kala Pharmaceuticals.
Upon completion of this activity, the participant should be able to:
Sponsored by 
Evolve Medical Education LLC (Evolve) is a COPE-accredited administrator.
This activity, COPE Activity Number 124266, is accredited by COPE for continuing education for optometrists for 0.25 hours.
Course #: 78861-TD
Activity #: 124266
COPE advises optometrists to contact the State or Provincial Board where they are licensed for verification of what is acceptable for license renewal.
In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.
Douglas K. Devries, OD
Co-Founder
Eye Care Associates of Nevada
Sparks, NV
DISCLOSURE POLICY
It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all financial relationships prior to this educational activity.
The following faculty/staff members have the following financial relationships with ineligible companies.
Douglas K. Devries, OD, has had a financial relationship or affiliation with the following ineligible companies in the form of Advisory Board: Alcon, Allergan/AbbVie, Avellino, Azura Ophthalmics, Bausch Health, BioTissue, Bruder, Dompé, Eyevance Pharmaceuticals, Johnson & Johnson Vision, Kala Pharmaceuticals, Lumenis, Novartis, OcuSoft, Orasis Pharmaceuticals, Oyster Point Pharma, Quidel, Science Based Health, Sun Pharmaceutical Industries, Tarsus, TearLab, TearScience, Théa Pharma, and Visus. Speaker's Bureau: Alcon, Allergan/AbbVie, Bausch Health, BioTissue, Dompé, Eyevance Pharmaceuticals, Johnson & Johnson Vision, Kala Pharmaceuticals, Lumenis, Novartis, OcuSoft, Oyster Point Pharma, Quidel, Science Based Health, Sun Pharmaceutical Industries, and TearScience. Stock/Shareholder: Opthalmic Resources.
Evolve and The Fundingsland Group staff, planners, and reviewers have no financial relationships with ineligible companies.
OFF-LABEL STATEMENT
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
DISCLAIMER
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve, The Fundingsland Group, or Kala Pharmaceuticals.
Release Date:
Expiration Date:
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Walter O. Whitley, OD, FAAO
Nate Lighthizer, OD, FAAO, FAAOMS
Jessica Steen, OD, FAAO, Dipl-ABO
Christina Y. Weng, MD, MBA, FASRS
Mark T. Dunbar, OD, FAAO
David A. Eichenbaum, MD, FAAO
Jaclyn Garlich, OD, FAAO
Mohammad R. Rafieetary, OD, FAAO, FORS, ABO
John Kitchens, MD
Sara LeMay, OD
John Kitchens, MD
Sara LeMay, OD
